{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T18:32:55Z","timestamp":1780511575922,"version":"3.54.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Federal Ministry of Education and Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"federal state of Baden-Wuerttemberg"},{"name":"DFG-funded Graduate School \u2018Konstanz Research School Chemical Biology"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.tox.2019.03.013","type":"journal-article","created":{"date-parts":[[2019,3,30]],"date-time":"2019-03-30T11:24:36Z","timestamp":1553945076000},"page":"29-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Comparison of Aristolochic acid I derived DNA adduct levels in human renal toxicity models"],"prefix":"10.1016","volume":"420","author":[{"given":"Heinke","family":"Bastek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tabea","family":"Zubel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Stemmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aswin","family":"Mangerich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sascha","family":"Beneke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel R.","family":"Dietrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tox.2019.03.013_bib0005","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/ijc.20316","article-title":"Aristolochic acid (AA)-DNA adduct as marker of AA exposure and risk factor for AA nephropathy-associated cancer","volume":"111","author":"Arlt","year":"2004","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.tox.2019.03.013_bib0010","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1128\/MCB.01435-12","article-title":"Delineation of the key aspects in the regulation of epithelial monolayer formation","volume":"33","author":"Aschauer","year":"2013","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.tox.2019.03.013_bib0015","article-title":"Expression of xenobiotic transporters in the human renal proximal tubule cell line RPTEC\/TERT1","author":"Aschauer","year":"2014","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.tox.2019.03.013_bib0020","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1515\/znc-2004-5-628","article-title":"Comparison of the global genomic and transcription-coupled repair rates of different lesions in human cells","volume":"59","author":"Atanassov","year":"2004","journal-title":"Z. Naturforsch. C"},{"key":"10.1016\/j.tox.2019.03.013_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mrgentox.2014.01.012","article-title":"The effect of aristolochic acid I on expression of NAD (P) H: quinone oxidoreductase in mice and rats\u2014a comparative study","volume":"768","author":"B\u00e1rta","year":"2014","journal-title":"Mutat. Res. Toxicol. Environ. Mutagen."},{"key":"10.1016\/j.tox.2019.03.013_bib0030","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/carcin\/18.5.1063","article-title":"32P-post-labelling analysis of DNA adducts formed by aristolochic acid in tissues from patients with Chinese herbs nephropathy","volume":"18","author":"Bieler","year":"1997","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.tox.2019.03.013_bib0035","first-page":"949","article-title":"Potent induction of phase 2 enzymes in human prostate cells by sulforaphane","volume":"10","author":"Brooks","year":"2001","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.tox.2019.03.013_bib0040","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1582-4934.2011.01258.x","article-title":"Why is the partial oxygen pressure of human tissues a crucial parameter? Small molecules and hypoxia","volume":"15","author":"Carreau","year":"2011","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.tox.2019.03.013_bib0045","first-page":"2","article-title":"Human liver-kidney model elucidates the mechanisms of aristolochic acid nephrotoxicity","author":"Chang","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.tox.2019.03.013_bib0050","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2165\/00002018-200326010-00004","article-title":"Aristolochic acid and \u201cChinese herbs nephropathy\u201d: a review of the evidence to date","volume":"26","author":"Cosyns","year":"2003","journal-title":"Drug Saf."},{"key":"10.1016\/j.tox.2019.03.013_bib0055","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/ki.2008.129","article-title":"Aristolochic acid nephropathy: a worldwide problem","volume":"74","author":"Debelle","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.tox.2019.03.013_bib0060","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0272-6386(12)80178-8","article-title":"Pathologic aspects of a newly described nephropathy related to the prolonged use of Chinese herbs","volume":"24","author":"Depierreux","year":"1994","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.tox.2019.03.013_bib0065","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1124\/jpet.111.180984","article-title":"Physiological and molecular characterization of aristolochic acid transport by the kidney","volume":"338","author":"Dickman","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tox.2019.03.013_bib0070","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0891-5849(00)00300-2","article-title":"Persuasive evidence that quinone reductase type 1 (DT diaphorase) protects cells against the toxicity of electrophiles and reactive forms of oxygen","volume":"29","author":"Dinkova-Kostova","year":"2000","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.tox.2019.03.013_bib0075","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1124\/dmd.105.008706","article-title":"Quantitative determination of aristolochic acid-derived DNA adducts in rats using 32P-postlabeling\/polyacrylamide gel electrophoresis analysis","volume":"34","author":"Dong","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tox.2019.03.013_bib0080","article-title":"Guideline on bioanalytical method validation","author":"European Medicines Agency","year":"2011","journal-title":"Comm. Med. Prod. Hum. Use."},{"key":"10.1016\/j.tox.2019.03.013_bib0085","series-title":"Methods in Enzymology","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0076-6879(04)82014-7","article-title":"The \u201cProchaska\u201d microtiter plate bioassay for inducers of NQO1","author":"Fahey","year":"2004"},{"key":"10.1016\/j.tox.2019.03.013_bib0090","series-title":"Guideline for Industry: Text on Validation of Analytical Procedures: ICH Q2A. Rockville, MD Mar 1, 995","author":"FDA, U.S","year":"1995"},{"key":"10.1016\/j.tox.2019.03.013_bib0095","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1021\/tx0601713","article-title":"Novel LC-ESI\/MS\/MSn method for the characterization and quantification of 2 \u2018-Deoxyguanosine adducts of the dietary carcinogen 2-Amino-1-methyl-6-phenylimidazo [4, 5-b] pyridine by 2-D linear quadrupole ion trap mass spectrometry","volume":"20","author":"Goodenough","year":"2007","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.tox.2019.03.013_bib0100","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/7857186","article-title":"Sulforaphane and other nutrigenomic Nrf2 activators: can the clinician\u2019s expectation Be matched by the reality?","volume":"2016","author":"Houghton","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.tox.2019.03.013_bib0105","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3390\/ijms18020297","article-title":"An integrated view of aristolochic acid nephropathy: update of the literature","volume":"18","author":"Jadot","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tox.2019.03.013_bib0110","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/ki.2011.371","article-title":"Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid","volume":"81","author":"Jelakovi","year":"2011","journal-title":"Kidney Int."},{"key":"10.1016\/j.tox.2019.03.013_bib0115","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3858\/emm.2010.42.8.058","article-title":"Human telomerase catalytic subunit (hTERT) suppresses p53-mediated anti-apoptotic response via induction of basic fibroblast growth factor","volume":"42","author":"Jin","year":"2010","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.tox.2019.03.013_bib0120","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/bcp.12086","article-title":"Renal drug metabolism in humans: the potential for drug-endobiotic interactions involving cytochrome P450 (CYP) and UDP-glucuronosyltransferase (UGT)","volume":"76","author":"Knights","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.tox.2019.03.013_bib0125","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/toxsci\/kfr050","article-title":"Role of cytochromes P450 1A1\/2 in detoxication and activation of carcinogenic aristolochic acid I: studies with the hepatic NADPH: cytochrome P450 reductase null (HRN) mouse model","volume":"121","author":"Levov\u00e1","year":"2011","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2019.03.013_bib0130","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/ijc.21480","article-title":"Human sulphotransferases are involved in the activation of aristolochic acids and are expressed in renal target tissue","volume":"118","author":"Meinl","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.tox.2019.03.013_bib0135","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1056\/NEJM200006083422301","article-title":"Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi)","volume":"342","author":"Nortier","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tox.2019.03.013_bib0140","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/ndt\/18.2.426","article-title":"Invasive urothelial carcinoma after exposure to Chinese herbal medicine containing aristolochic acid may occur without severe renal failure","volume":"18","author":"Nortier","year":"2003","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.tox.2019.03.013_bib0145","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/toxsci\/63.2.256","article-title":"Species-, sex-, and cell type-specific effects of ochratoxin A and B","volume":"63","author":"O\u2019Brien","year":"2001","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2019.03.013_bib0150","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/carcin\/11.2.313","article-title":"Aristolochic acid binds covalently to the exocyclic amino group of purine nucleotides in DNA","volume":"11","author":"Pfau","year":"1990","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.tox.2019.03.013_bib0155","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3389\/fphys.2017.00211","article-title":"Mitochondrial reactive oxygen species and kidney hypoxia in the development of diabetic nephropathy","volume":"8","author":"Schiffer","year":"2017","journal-title":"Front. Physiol."},{"key":"10.1016\/j.tox.2019.03.013_bib0160","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1093\/nar\/gkr1095","article-title":"Lack of recognition by global-genome nucleotide excision repair accounts for the high mutagenicity and persistence of aristolactam-DNA adducts","volume":"40","author":"Sidorenko","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tox.2019.03.013_bib0165","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1093\/carcin\/bgu095","article-title":"Bioactivation of the human carcinogen aristolochic acid","volume":"35","author":"Sidorenko","year":"2014","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.tox.2019.03.013_bib0170","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s12011-015-0339-y","article-title":"The RPTEC\/TERT1 cell line as an improved tool for in vitro nephrotoxicity assessments","volume":"166","author":"Simon-Friedt","year":"2015","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.tox.2019.03.013_bib0175","doi-asserted-by":"crossref","first-page":"4052","DOI":"10.1158\/0008-5472.CAN-06-3587","article-title":"Carcinogen-specific gene expression profiles in short-term treated Eker and wild-type rats indicative of pathways involved in renal tumorigenesis","volume":"67","author":"Stemmer","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.tox.2019.03.013_bib0180","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1093\/carcin\/bgg119","article-title":"Human cytosolic enzymes involved in the metabolic activation of carcinogenic aristolochic acid: evidence for reductive activation by human NAD(P)H:quinone oxidoreductase","volume":"24","author":"Stiborova","year":"2003","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.tox.2019.03.013_bib0185","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/ijc.20564","article-title":"Human hepatic and renal microsomes, cytochromes P450 1A1\/2, NADPH:cytochrome P450 reductase and prostaglandin H synthase mediate the formation of aristolochic acid-DNA adducts found in patients with urothelial cancer","volume":"113","author":"Stiborova","year":"2005","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.tox.2019.03.013_bib0190","article-title":"The role of biotransformation enzymes in the development of renal injury and urothelial cancer caused by aristolochic acid: urgent questions and difficult answers","volume":"153","author":"Stiborova","year":"2009","journal-title":"Biomed. Pap. Med. Fac. Palacky Univ. Olomouc"},{"key":"10.1016\/j.tox.2019.03.013_bib0195","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/em.20642","article-title":"The human carcinogen aristolochic acid i is activated to form DNA adducts by human NAD(P)H:quinone oxidoreductase without the contribution of acetyltransferases or sulfotransferases","volume":"52","author":"Stiborova","year":"2011","journal-title":"Environ. Mol. Mutagen"},{"key":"10.1016\/j.tox.2019.03.013_bib0200","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/toxsci\/kfr306","article-title":"Bioactivation versus detoxication of the urothelial carcinogen aristolochic acid I by human cytochrome P450 1A1 and 1A2","volume":"125","author":"Stiborova","year":"2012","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2019.03.013_bib0205","doi-asserted-by":"crossref","first-page":"27561","DOI":"10.3390\/ijms161126047","article-title":"A mechanism of O-Demethylation of aristolochic acid I by cytochromes P450 and their contributions to this reaction in human and rat livers: experimental and theoretical approaches","volume":"16","author":"Stiborov\u00e1","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tox.2019.03.013_bib0210","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.3390\/ijms18102144","article-title":"DNA adducts formed by aristolochic acid are unique biomarkers of exposure and explain the initiation phase of upper urothelial cancer","volume":"18","author":"Stiborov\u00e1","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tox.2019.03.013_bib0215","doi-asserted-by":"crossref","first-page":"5578","DOI":"10.1038\/srep05578","article-title":"Fluorescence detection of cellular nucleotide excision repair of damaged DNA","volume":"4","author":"Toga","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tox.2019.03.013_bib0220","doi-asserted-by":"crossref","first-page":"F1365","DOI":"10.1152\/ajprenal.90405.2008","article-title":"hTERT alone immortalizes epithelial cells of renal proximal tubules without changing their functional characteristics","volume":"295","author":"Wieser","year":"2008","journal-title":"AJP Ren. Physiol."},{"key":"10.1016\/j.tox.2019.03.013_bib0225","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/ki.2008.103","article-title":"Hepatic cytochrome P450s metabolize aristolochic acid and reduce its kidney toxicity","volume":"73","author":"Xiao","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.tox.2019.03.013_bib0230","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1021\/mp100418u","article-title":"Critical role of organic anion transporters 1 and 3 in kidney accumulation and toxicity of aristolochic acid I","volume":"8","author":"Xue","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.tox.2019.03.013_bib0235","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1021\/tx3000889","article-title":"Biomonitoring of Aristolactam-DNA adducts in human tissues using ultra-performance liquid Chromatography\/Ion-Trap mass spectrometry","volume":"25","author":"Yun","year":"2012","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.tox.2019.03.013_bib0240","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1021\/acs.chemrestox.7b00218","article-title":"A rapid throughput method to extract DNA from formalin-fixed paraffin-embedded tissues for biomonitoring carcinogenic DNA adducts","volume":"30","author":"Yun","year":"2017","journal-title":"Chem. Res. Toxicol."}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X19300733?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X19300733?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T23:40:21Z","timestamp":1759534821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X19300733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":48,"alternative-id":["S0300483X19300733"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2019.03.013","relation":{},"ISSN":["0300-483X"],"issn-type":[{"value":"0300-483X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of Aristolochic acid I derived DNA adduct levels in human renal toxicity models","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2019.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}